DK0462506T3 - Farmaceutiske kombinationspræparater indeholdende cefotaxim og xanthinderivater og anvendelse deraf - Google Patents

Farmaceutiske kombinationspræparater indeholdende cefotaxim og xanthinderivater og anvendelse deraf

Info

Publication number
DK0462506T3
DK0462506T3 DK91109673.3T DK91109673T DK0462506T3 DK 0462506 T3 DK0462506 T3 DK 0462506T3 DK 91109673 T DK91109673 T DK 91109673T DK 0462506 T3 DK0462506 T3 DK 0462506T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
xanthine derivatives
combination pharmaceutical
containing cefotaxime
Prior art date
Application number
DK91109673.3T
Other languages
Danish (da)
English (en)
Inventor
Elmar Dr Schrinner
Norbert Dr Klesel
Michael Dr Limbert
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0462506T3 publication Critical patent/DK0462506T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91109673.3T 1990-06-20 1991-06-13 Farmaceutiske kombinationspræparater indeholdende cefotaxim og xanthinderivater og anvendelse deraf DK0462506T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4019571A DE4019571A1 (de) 1990-06-20 1990-06-20 Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung

Publications (1)

Publication Number Publication Date
DK0462506T3 true DK0462506T3 (da) 1996-11-25

Family

ID=6408686

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91109673.3T DK0462506T3 (da) 1990-06-20 1991-06-13 Farmaceutiske kombinationspræparater indeholdende cefotaxim og xanthinderivater og anvendelse deraf

Country Status (26)

Country Link
US (1) US5350753A (pt)
EP (1) EP0462506B1 (pt)
JP (1) JP3213339B2 (pt)
KR (1) KR100205161B1 (pt)
CN (1) CN1057390A (pt)
AT (1) ATE144901T1 (pt)
AU (1) AU643291B2 (pt)
BR (1) BR9102554A (pt)
CA (1) CA2044977A1 (pt)
CZ (1) CZ282285B6 (pt)
DE (2) DE4019571A1 (pt)
DK (1) DK0462506T3 (pt)
ES (1) ES2093656T3 (pt)
FI (1) FI912968A (pt)
GR (1) GR3021568T3 (pt)
HR (1) HRP940708B1 (pt)
HU (1) HU212937B (pt)
IE (1) IE76290B1 (pt)
IL (1) IL98535A (pt)
MX (1) MX26309A (pt)
NO (1) NO912382L (pt)
NZ (1) NZ238580A (pt)
PT (1) PT98028B (pt)
RU (1) RU2095063C1 (pt)
YU (1) YU48415B (pt)
ZA (1) ZA914709B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1090795A (en) 1993-11-12 1995-05-29 Cell Therapeutics, Inc. Method for preventing tissue injury from hypoxia
PT812844E (pt) 1996-06-07 2003-03-31 Hoechst Ag Utilizacao de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparacao
JP2006510357A (ja) * 2002-11-22 2006-03-30 ザ ジョーンズ ホプキンズ ユニバーシティ 認識障害の処置のための標的
KR101315483B1 (ko) 2011-06-23 2013-10-07 주식회사 아리바이오 항생제 및 라이소포스파티딜콜린을 포함하는 면역 증강 또는 세균성 감염 질환 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel

Also Published As

Publication number Publication date
DE59108321D1 (de) 1996-12-12
CS187891A3 (en) 1992-02-19
DE4019571A1 (de) 1992-01-02
CZ282285B6 (cs) 1997-06-11
JP3213339B2 (ja) 2001-10-02
HRP940708B1 (en) 1998-12-31
PT98028A (pt) 1992-03-31
HU912048D0 (en) 1991-12-30
BR9102554A (pt) 1992-01-21
FI912968A (fi) 1991-12-21
CA2044977A1 (en) 1991-12-21
IL98535A0 (en) 1992-07-15
KR100205161B1 (ko) 1999-07-01
US5350753A (en) 1994-09-27
EP0462506B1 (de) 1996-11-06
KR920000322A (ko) 1992-01-29
HU212937B (en) 1996-12-30
HUT57986A (en) 1992-01-28
FI912968A0 (fi) 1991-06-18
YU48415B (sh) 1998-07-10
EP0462506A1 (de) 1991-12-27
IE76290B1 (en) 1997-10-08
NZ238580A (en) 1993-10-26
ZA914709B (en) 1992-03-25
AU7848291A (en) 1992-01-02
IE912107A1 (en) 1992-01-01
NO912382L (no) 1991-12-23
ES2093656T3 (es) 1997-01-01
HRP940708A2 (en) 1997-02-28
GR3021568T3 (en) 1997-02-28
PT98028B (pt) 1998-11-30
CN1057390A (zh) 1992-01-01
JPH04230219A (ja) 1992-08-19
RU2095063C1 (ru) 1997-11-10
YU108291A (sh) 1995-03-27
NO912382D0 (no) 1991-06-19
ATE144901T1 (de) 1996-11-15
IL98535A (en) 1996-01-19
MX26309A (es) 1994-02-28
AU643291B2 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
NO933077D0 (no) Anvendelse av il-4-reseptor for terapi i profylakse og diagnostikk av allergiske, virale og parasitiske og bakterielle sykdommer
FI943363A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten /1,4/oksatsino/3,4-a//2/bentsatsepiinijohdannaisten valmistamiseksi
HU9302491D0 (en) Neolignane derivatives and pharmaceutical compositions containing them
NO891703D0 (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
DK0462506T3 (da) Farmaceutiske kombinationspræparater indeholdende cefotaxim og xanthinderivater og anvendelse deraf
ES8103094A1 (es) Un procedimiento para la preparacion de 1,1-dioxido de acidopenicilanico y esteres del mismo
NZ219083A (en) N-substituted erythromyclylamines and pharmaceutical compositions
EP0416810A3 (en) Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates
NZ223333A (en) 3-phenyl-7h-thiazole (3,2-b (1,2, triazin-7-one derivatives and pharmaceutical compositions
NZ218227A (en) Cephalosporin derivatives and pharmaceutical compositions
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
MY101875A (en) Lankacidin derivatives and production thereof.
UA26433A (uk) Спосіб отримаhhя аміhотіазолільhих похідhих цефалоспориhу та їх солей
JPS5692892A (en) Penicillin and cephalosporin derivatives* their manufacture and bacteria infection remedy as effective component thereof